US govt PrEP patents are invalid, Gilead tells court

27-01-2020

Rory O'Neill

US govt PrEP patents are invalid, Gilead tells court

II Studio / Shutterstock.com

Gilead Sciences has accused a US government agency of withholding information from the US Patent and Trademark Office (USPTO) when filing two patents for HIV pre-exposure prophylaxis (PrEP).


Gilead Sciences, US Patent and Trademark Office, USPTO, PrEP, pre-exposure prophylaxis, HIV, CDC, Centers for Disease Control and Prevention

LSIPR